Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — January 2026

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

UNITED THERAPEUTICS Corp (UTHR)

BENKOWITZ MICHAEL — PRESIDENT AND COO
Jan 12, 2026
Sale
Shares
14,625
Price
$479.51
Total Value
$7.01M
Shares Held After
0
% of Holdings
100.0%

Liquidia Corp (LQDA)

Krepp Sarah — Chief Human Resource Officer
Jan 12, 2026
Sale
Shares
13,165
Price
$37.43
Total Value
$492.77K
Shares Held After
140,769
% of Holdings
8.6%

Liquidia Corp (LQDA)

Moomaw Scott — Chief Commercial Officer
Jan 12, 2026
Sale
Shares
20,533
Price
$37.43
Total Value
$768.55K
Shares Held After
154,514
% of Holdings
11.7%

Liquidia Corp (LQDA)

Kaseta Michael — CFO and COO
Jan 12, 2026
Sale
Shares
36,932
Price
$37.43
Total Value
$1.38M
Shares Held After
350,919
% of Holdings
9.5%

Liquidia Corp (LQDA)

Adair Jason — Chief Business Officer
Jan 12, 2026
Sale
Shares
13,548
Price
$37.43
Total Value
$507.10K
Shares Held After
184,174
% of Holdings
6.9%

Liquidia Corp (LQDA)

Schundler Russell — General Counsel
Jan 12, 2026
Sale
Shares
27,289
Price
$37.43
Total Value
$1.02M
Shares Held After
579,394
% of Holdings
4.5%

Liquidia Corp (LQDA)

JEFFS ROGER — Director
Jan 12, 2026
Sale
Shares
66,610
Price
$37.43
Total Value
$2.49M
Shares Held After
1,037,528
% of Holdings
6.0%

Liquidia Corp (LQDA)

Boyle Dana — Chief Accounting Officer
Jan 12, 2026
Sale
Shares
11,047
Price
$37.43
Total Value
$413.49K
Shares Held After
156,700
% of Holdings
6.6%

Liquidia Corp (LQDA)

Saggar Rajeev — Chief Medical Officer
Jan 12, 2026
Sale
Shares
21,142
Price
$37.43
Total Value
$791.35K
Shares Held After
176,883
% of Holdings
10.7%

IRADIMED CORP (IRMD)

Susi Roger E. — Director
Jan 12, 2026
Sale
Shares
112
Price
$98.15
Total Value
$10.99K
Shares Held After
2,272,500
% of Holdings
0.0%

IRADIMED CORP (IRMD)

Susi Roger E. — Director
Jan 12, 2026
Sale
Shares
4,888
Price
$97.43
Total Value
$476.24K
Shares Held After
2,272,612
% of Holdings
0.2%

BRUKER CORP (BRKR)

Munch Mark — EXEC VP&PRES BRUKER NANO INC.
Jan 12, 2026
Sale
Shares
7,000
Price
$55.00
Total Value
$385.00K
Shares Held After
128,443
% of Holdings
5.2%

INSMED Inc (INSM)

Lewis William — Director
Jan 12, 2026
Sale
Shares
315
Price
$174.86
Total Value
$55.08K
Shares Held After
306,891
% of Holdings
0.1%

INSMED Inc (INSM)

Lewis William — Director
Jan 12, 2026
Sale
Shares
297
Price
$172.36
Total Value
$51.19K
Shares Held After
307,206
% of Holdings
0.1%

INSMED Inc (INSM)

Lewis William — Director
Jan 12, 2026
Sale
Shares
297
Price
$171.31
Total Value
$50.88K
Shares Held After
307,503
% of Holdings
0.1%

INSMED Inc (INSM)

Lewis William — Director
Jan 12, 2026
Sale
Shares
160
Price
$170.24
Total Value
$27.24K
Shares Held After
307,800
% of Holdings
0.1%

INSMED Inc (INSM)

Lewis William — Director
Jan 12, 2026
Sale
Shares
6,996
Price
$169.57
Total Value
$1.19M
Shares Held After
307,960
% of Holdings
2.2%

INSMED Inc (INSM)

Lewis William — Director
Jan 12, 2026
Sale
Shares
7,176
Price
$168.63
Total Value
$1.21M
Shares Held After
314,956
% of Holdings
2.2%

INSMED Inc (INSM)

Lewis William — Director
Jan 12, 2026
Sale
Shares
3,974
Price
$167.73
Total Value
$666.56K
Shares Held After
322,132
% of Holdings
1.2%

Arcellx, Inc. (ACLX)

Heery Christopher — CHIEF MEDICAL OFFICER
Jan 12, 2026
Sale
Shares
6,131
Price
$64.15
Total Value
$393.29K
Shares Held After
37,068
% of Holdings
14.2%

Zymeworks Inc. (ZYME)

Smith Jeffrey T L — EVP & Chief Medical Officer
Jan 12, 2026
Sale
Shares
9,310
Price
$22.67
Total Value
$211.09K
Shares Held After
26,708
% of Holdings
25.8%

Zymeworks Inc. (ZYME)

Moore Paul Andrew — Chief Scientific Officer
Jan 12, 2026
Sale
Shares
9,560
Price
$22.67
Total Value
$216.76K
Shares Held After
48,497
% of Holdings
16.5%
Jan 12, 2026
Purchase
Shares
144,443
Price
$18.00
Total Value
$2.60M
Shares Held After
347,305
% of Holdings
41.6%
Jan 12, 2026
Purchase
Shares
2,077,779
Price
$18.00
Total Value
$37.40M
Shares Held After
4,348,658
% of Holdings
47.8%
Jan 12, 2026
Sale
Shares
30,424
Price
$22.67
Total Value
$689.82K
Shares Held After
226,842
% of Holdings
11.8%

Acumen Pharmaceuticals, Inc. (ABOS)

Meisner Derek M — Chief Legal Officer & Corp Sec
Jan 12, 2026
Sale
Shares
8,548
Price
$1.71
Total Value
$14.66K
Shares Held After
83,800
% of Holdings
9.3%
Jan 12, 2026
Sale
Shares
5,388
Price
$1.73
Total Value
$9.31K
Shares Held After
593,510
% of Holdings
0.9%

PTC THERAPEUTICS, INC. (PTCT)

Pauwels Eric — CHIEF BUSINESS OFFICER
Jan 12, 2026
Sale
Shares
1,024
Price
$78.70
Total Value
$80.59K
Shares Held After
80,141
% of Holdings
1.3%
Jan 12, 2026
Purchase
Shares
22,545
Price
$18.00
Total Value
$405.81K
Shares Held After
157,387
% of Holdings
14.3%
Jan 12, 2026
Purchase
Shares
812,455
Price
$18.00
Total Value
$14.62M
Shares Held After
5,671,825
% of Holdings
14.3%
Jan 12, 2026
Sale
Shares
58,980
Price
$0.57
Total Value
$33.62K
Shares Held After
2,309,869
% of Holdings
2.5%
Jan 12, 2026
Purchase
Shares
22,545
Price
$18.00
Total Value
$405.81K
Shares Held After
157,387
% of Holdings
14.3%
Jan 12, 2026
Purchase
Shares
812,455
Price
$18.00
Total Value
$14.62M
Shares Held After
5,671,825
% of Holdings
14.3%

Clene Inc. (CLNN)

Ugwumba Chidozie — 10% Owner
Jan 12, 2026
Sale
Shares
32,705
Price
$5.50
Total Value
$179.88K
Shares Held After
708,587
% of Holdings
4.4%
Jan 9, 2026
Sale
Shares
260,411
Price
$1.93
Total Value
$501.37K
Shares Held After
47,281
% of Holdings
84.6%
Jan 9, 2026
Sale
Shares
269,321
Price
$1.93
Total Value
$518.52K
Shares Held After
192,307
% of Holdings
58.3%
Jan 9, 2026
Purchase
Shares
5,000
Price
$1.88
Total Value
$9.40K
Shares Held After
5,728
% of Holdings
87.3%
Jan 9, 2026
Purchase
Shares
27,485
Price
$22.05
Total Value
$606.14K
Shares Held After
15,453,629
% of Holdings
0.2%

Mineralys Therapeutics, Inc. (MLYS)

Rodman David Malcom — Chief Medical Officer
Jan 9, 2026
Sale
Shares
2,170
Price
$33.27
Total Value
$72.20K
Shares Held After
61,804
% of Holdings
3.4%
Jan 9, 2026
Sale
Shares
213
Price
$40.16
Total Value
$8.55K
Shares Held After
38,659
% of Holdings
0.5%
Jan 9, 2026
Purchase
Shares
588,235
Price
$17.00
Total Value
$10.00M
Shares Held After
1,853,488
% of Holdings
31.7%

Enliven Therapeutics, Inc. (ELVN)

Patel Anish — CHIEF OPERATING OFFICER
Jan 9, 2026
Sale
Shares
243
Price
$28.50
Total Value
$6.93K
Shares Held After
215,011
% of Holdings
0.1%

Enliven Therapeutics, Inc. (ELVN)

Patel Anish — CHIEF OPERATING OFFICER
Jan 9, 2026
Sale
Shares
48,057
Price
$27.98
Total Value
$1.34M
Shares Held After
215,254
% of Holdings
18.3%
Jan 9, 2026
Sale
Shares
9,600
Price
$15.82
Total Value
$151.91K
Shares Held After
227,034
% of Holdings
4.1%

Royalty Pharma plc (RPRX)

Urist Marshall — EVP, Research & Investments
Jan 9, 2026
Sale
Shares
20,000
Price
$40.78
Total Value
$815.63K
Shares Held After
60,000
% of Holdings
25.0%
Jan 9, 2026
Sale
Shares
20,000
Price
$16.12
Total Value
$322.40K
Shares Held After
11,565
% of Holdings
63.4%
Jan 9, 2026
Sale
Shares
280
Price
$551.24
Total Value
$154.35K
Shares Held After
187,164
% of Holdings
0.1%
Jan 9, 2026
Sale
Shares
40
Price
$545.79
Total Value
$21.83K
Shares Held After
187,164
% of Holdings
0.0%
Jan 9, 2026
Sale
Shares
600
Price
$540.36
Total Value
$324.21K
Shares Held After
187,204
% of Holdings
0.3%
Jan 9, 2026
Sale
Shares
480
Price
$539.23
Total Value
$258.83K
Shares Held After
187,804
% of Holdings
0.3%
Version: v26.3.31